Skip to main content

Result releasedAnnolyse analysis published

NPAT fell 57.6% as net debt/EBITDA jumped to 1.91x, dividend suspended

Revenue down 11.2% and 140bps of gross margin loss have pushed leverage above its historical 0.51x-1.20x range and ended the interim dividend.

MFB revenue trajectory

Revenue context before the current result.

Loading chart...
FY23 was $175.7m, versus $194m in FY22.

MFB EBITDA margin

EBITDA margin across covered periods.

Loading chart...
  • FY22 MFB FY: Outside range high ebitda margin. 17.6%; 3-period range 9.6% to 10.4%. EBITDA margin: 17.6%, above normal range; 3-period mean 10.0%, range 9.6%-10.4%.
  • HY23 MFB HY: Outside range high ebitda margin. 12.2%; 3-period range 8.4% to 9.5%. EBITDA margin: 12.2%, above normal range; 3-period mean 8.9%, range 8.4%-9.5%.
EBITDA margin: 12.2%, above normal range; 3-period mean 8.9%, range 8.4%-9.5%.

MFB operating cash flow

Operating cash flow across covered periods.

Loading chart...
FY23 was $9.8m, versus $29.5m in FY22.

MFB working-capital movement

Operating working-capital absorption or release by reporting period.

Loading chart...
HY24 was -$0.7m, versus -$0.3m in FY23.

Market context

Valuation

These ratios pair a market close from around the result date with verified filing data. An unavailable metric means the required inputs were missing or unsuitable for comparison.

Prices as at close, 3 September 2026

Price and market cap

The latest close and share count context for the market price.

Market cap

$78.9m

i

End-of-day close multiplied by current shares on issue.

Profitability multiples

How the market price compares with recent earnings and cash-flow inputs.

P/E

11.78x

i

Recent market cap compared with trailing earnings.

EPS

0.03

i

Recent filing-derived earnings per share.

PEG

2.51x

i

P/E compared with recent earnings growth.

EV/EBITDA

4.93x

i

Enterprise value compared with recent EBITDA.

P/FCF

9.28x

i

Market cap compared with recent free cash flow.

P/B

1.09x

i

Market value compared with latest reported equity.

Income and investment-company measures

Yield and investment-company valuation where supported.

Dividend yield

6.1%

i

Trailing dividends compared with the latest close.

Total return

Not available

i

Available once dividend and adjustment data are verified.

Release date
23 November 2023
Published
22 April 2026

Key metrics

Numbers worth scanning first

HY24 vs HY23

Revenue

$83.8m

-11.2% ↓ vs $94.4m

EBITDA

$7.4m

-35.7% ↓ vs $11.5m

Net profit after tax

$2.5m

-57.6% ↓ vs $5.9m

Net cash inflow from operating activities

$4.9m

-10.1% ↓ vs $5.5m

Interim dividend per share

— vs 3.0c

Profit before tax

$3.5m

-57.3% ↓ vs $8.2m

Cash and cash equivalents

$0.15m

+13.4% ↑ vs $0.13m

Total assets

$107.6m

+1.1% ↑ vs $106.5m

Analysis ofMFB HY24Result releasedAnnolyse analysis published

What changed

Earnings collapsed faster than revenue and the balance sheet has absorbed the difference

Revenue fell 11.2% to NZ$83.8m, EBITDA fell 35.7% to NZ$7.4m, PBT fell 57.3% to NZ$3.5m and NPAT fell 57.6% to NZ$2.5m. Gross margin compressed 140bps to 47.9%.

Net debt/EBITDA jumped to 1.91x from 0.51x at HY23, which is above Annolyse's historical range of 0.51x-1.20x and the 0.83x historical mean. Gross borrowings rose 137.8% to NZ$14.3m. No interim dividend was declared, versus 3.0 cents at HY23.

This is an amended release for HY24, so the figures should be read as the corrected disclosure rather than the original announcement.

What matters

Leverage has moved outside its historical baseline

Net debt/EBITDA of 1.91x sits above the supplied 0.51x-1.20x range, driven by both the EBITDA contraction and an NZ$8.3m increase in gross borrowings. With EBITDA down 35.7%, leverage is being pushed up by both numerator and denominator at once, which compresses headroom against any covenant or future trading shock.

Operating leverage worked against the business despite volume growth. Bargain Box delivery volumes were up 12% and active customers rose to 61,600 from 57,500, yet revenue still fell 11.2% and gross margin slipped 140bps to 47.9%. That gap suggests pricing, basket size or product mix is moving the wrong way, and that volume gains in the value brand are not offsetting weakness elsewhere.

The dividend decision reframes capital allocation. HY23's 3.0 cent interim represented a 150% payout against that period's NPAT, which was not sustainable through a downturn. Suspending the interim conserves cash, but it also signals that the board is prioritising balance sheet repair over income to holders – a material change in the equity story.

Expectations

No forward targets have been disclosed for HY24

Annolyse's second-half shape context shows HY23 contributed 53.7% of FY23 revenue but 74.9% of FY23 NPAT, so the prior year was second-half-weighted on profit. That implied a 2H23 NPAT of only NZ$2.0m on EBITDA of NZ$6.7m.

Against that shape, the HY24 NPAT of NZ$2.5m does not yet establish a credible path back toward FY23's NZ$7.9m, because the second-half profile last year was already thin. Annualising current revenue gives NZ$167.7m versus FY23 reported revenue of NZ$175.7m, which leaves the trajectory pointing further down rather than recovering. The release does not provide enough forward commentary to size a 2H rebound.

Quality of result

Cash quality is the more reassuring side of the result

OCF/EBITDA was 66.6%, classified as within Annolyse's historical 47.7%-80.6% range, and pre-lease FCF of NZ$3.6m sits within the historical NZ$2.7m-NZ$6.1m range. Pre-lease FCF was 143.0% of NPAT, well ahead of HY23's 45.4%.

That FCF strength is partly mechanical. Capex was cut to NZ$1.3m from NZ$2.8m (1.6% of revenue versus 3.0% prior), which means lower investment is propping up the conversion ratio rather than improved working-capital discipline. Operating working-capital movement of NZ$-0.7m is within the historical range, debtor days at 1.2 are normal, and inventory days actually fell to 4.2. So the cash result is durable on a like-for-like basis but flattered by reduced reinvestment, which matters because it suggests near-term cash comfort has been bought partly at the cost of future capability.

Unresolved

Open questions

Why did revenue fall 11.2% while Bargain Box volumes rose 12% and active customers grew – is the mix shifting toward lower-priced baskets, or has pricing been reset?
What drove the NZ$8.3m increase in gross borrowings, and how much covenant headroom remains at 1.91x net debt/EBITDA?
When does management expect the dividend to resume, and against what leverage or earnings threshold?
Is the 140bps gross margin decline being addressed by cost-out actions, supplier renegotiation, or pricing, and what is the expected timing of recovery?
Has capex at 1.6% of revenue been rebased structurally, or is HY24 a deliberate underspend that will reverse in 2H?

This briefing cannot assess management's specific operating plan for 2H24, covenant terms on the increased borrowings, or the competitive dynamics affecting basket economics, because the supplied release excerpts do not address them.

Ask about MFB HY24

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Sign in to chat

Sign in to ask questions about My Food Bag Group's HY24 result.

Why did revenue fall 11.2% while Bargain Box volumes rose 12% and active customers grew – is the mix shifting toward lower-priced baskets, or has pricing been reset?Why does "Leverage has moved outside its historical baseline" matter?How strong was the cash and earnings quality in HY24?What should I watch next for MFB after HY24?

Checking account...

Data appendix

Show analytical metrics

Open to load analytical metrics.

Show key metrics table

Open to load key metrics.

Sources

Current period

Prior comparable period

Full-year context

Release context

Results of 2023 Annual Meeting

HY24 / commentary

Get notified when MFB publishes next

Get the next My Food Bag Group briefing and related NZX reporting-season updates by email.